ÂÜÀòÂÒÂ×

Gui-Dong Zhu serves as the CEO of SPARX Biopharmaceutical Corp since May 2018, leading a company focused on developing innovative immuno-oncology therapies aimed at enhancing human immunity. Additionally, Gui-Dong Zhu has been the CEO and Chairman of Yao Yuan-Academy for Pharma Innovation since January 2011, where significant contributions to pharmaceutical innovation have occurred. Prior roles include President at AbbVie from January 2013 to April 2018, and a series of positions at Abbott, culminating in the role of Associate Research Fellow, from August 1996 to December 2012. Gui-Dong Zhu also spent time at the University of California from October 1993 to July 1996 as a Post-Doc/Staff, further establishing a robust background in research and development within the pharmaceutical sector.